BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Costi S, Morris LS, Collins A, Fernandez NF, Patel M, Xie H, Kim-Schulze S, Stern ER, Collins KA, Cathomas F, Parides MK, Whitton AE, Pizzagalli DA, Russo SJ, Murrough JW. Peripheral immune cell reactivity and neural response to reward in patients with depression and anhedonia. Transl Psychiatry 2021;11:565. [PMID: 34741019 DOI: 10.1038/s41398-021-01668-1] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 6.5] [Reference Citation Analysis]
Number Citing Articles
1 Goldsmith DR, Bekhbat M, Mehta ND, Felger JC. Inflammation-Related Functional and Structural Dysconnectivity as a Pathway to Psychopathology. Biol Psychiatry 2023;93:405-18. [PMID: 36725140 DOI: 10.1016/j.biopsych.2022.11.003] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
2 Petrican R, Fornito A. Adolescent Neurodevelopment and Psychopathology: The Interplay between Adversity Exposure and Genetic Risk for Accelerated Brain Ageing. Developmental Cognitive Neuroscience 2023. [DOI: 10.1016/j.dcn.2023.101229] [Reference Citation Analysis]
3 Johnston JN, Greenwald MS, Henter ID, Kraus C, Mkrtchian A, Clark NG, Park LT, Gold P, Zarate CA Jr, Kadriu B. Inflammation, stress and depression: An exploration of ketamine's therapeutic profile. Drug Discov Today 2023;28:103518. [PMID: 36758932 DOI: 10.1016/j.drudis.2023.103518] [Reference Citation Analysis]
4 Singh B, Vande Voort JL, Riva-Posse P, Pazdernik VM, Frye MA, Tye SJ. Ketamine-Associated Change in Anhedonia and mTOR Expression in Treatment-Resistant Depression. Biol Psychiatry 2023:S0006-3223(22)01699-7. [PMID: 36707268 DOI: 10.1016/j.biopsych.2022.10.007] [Reference Citation Analysis]
5 Felger JC. Increased Inflammation and Treatment of Depression: From Resistance to Reuse, Repurposing, and Redesign. Adv Neurobiol 2023;30:387-416. [PMID: 36928859 DOI: 10.1007/978-3-031-21054-9_16] [Reference Citation Analysis]
6 Polityńska B, Pokorska O, Wojtukiewicz AM, Sawicka M, Myśliwiec M, Honn KV, Tucker SC, Wojtukiewicz MZ. Is depression the missing link between inflammatory mediators and cancer? Pharmacol Ther 2022;240:108293. [PMID: 36216210 DOI: 10.1016/j.pharmthera.2022.108293] [Reference Citation Analysis]
7 Liu Q, Ely BA, Stern ER, Xu J, Kim JW, Pick DG, Alonso CM, Gabbay V. Neural function underlying reward expectancy and attainment in adolescents with diverse psychiatric symptoms. Neuroimage Clin 2022;36:103258. [PMID: 36451362 DOI: 10.1016/j.nicl.2022.103258] [Reference Citation Analysis]
8 Nguyen TNB, Ely BA, Pick D, Patel M, Xie H, Kim-Schulze S, Gabbay V. Clenbuterol attenuates immune reaction to lipopolysaccharide and its relationship to anhedonia in adolescents. Brain Behav Immun 2022;106:89-99. [PMID: 35914697 DOI: 10.1016/j.bbi.2022.07.163] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
9 Wijaya MT, Jin R, Liu X, Zhang R, Lee TM. Towards a multidimensional model of inflamed depression. Brain, Behavior, & Immunity - Health 2022. [DOI: 10.1016/j.bbih.2022.100564] [Reference Citation Analysis]
10 Toenders YJ, Schmaal L, Nawijn L, Han LKM, Binnewies J, van der Wee NJA, van Tol MJ, Veltman DJ, Milaneschi Y, Lamers F, Penninx BWJH. The association between clinical and biological characteristics of depression and structural brain alterations. J Affect Disord 2022;312:268-74. [PMID: 35760189 DOI: 10.1016/j.jad.2022.06.056] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
11 Bekhbat M, Ulukaya GB, Bhasin MK, Felger JC, Miller AH. Cellular and immunometabolic mechanisms of inflammation in depression: Preliminary findings from single cell RNA sequencing and a tribute to Bruce McEwen. Neurobiology of Stress 2022;19:100462. [DOI: 10.1016/j.ynstr.2022.100462] [Reference Citation Analysis]
12 Boukezzi S, Costi S, Shin LM, Kim-Schulze S, Cathomas F, Collins A, Russo SJ, Morris LS, Murrough JW. Exaggerated amygdala response to threat and association with immune hyperactivity in depression. Brain Behav Immun 2022;104:205-12. [PMID: 35636614 DOI: 10.1016/j.bbi.2022.05.015] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
13 Kelly CA, Freeman KB, Schumacher JA. Treatment-Resistant Depression with Anhedonia: Integrating Clinical and Preclinical Approaches to Investigate Distinct Phenotypes. Neuroscience & Biobehavioral Reviews 2022. [DOI: 10.1016/j.neubiorev.2022.104578] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
14 Bekhbat M, Li Z, Mehta ND, Treadway MT, Lucido MJ, Woolwine BJ, Haroon E, Miller AH, Felger JC. Functional connectivity in reward circuitry and symptoms of anhedonia as therapeutic targets in depression with high inflammation: evidence from a dopamine challenge study. Mol Psychiatry 2022;27:4113-21. [PMID: 35927580 DOI: 10.1038/s41380-022-01715-3] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
15 Nguyen TNB, Ely BA, Pick D, Patel M, Xie H, Kim-schulze S, Gabbay V. Clenbuterol Attenuates Immune Reaction to Lipopolysaccharide and Its Relationship to Anhedonia in Adolescents.. [DOI: 10.1101/2021.08.07.455522] [Reference Citation Analysis]